| __timestamp | Apellis Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 242549000 |
| Thursday, January 1, 2015 | 13730311 | 245098000 |
| Friday, January 1, 2016 | 22978599 | 147600000 |
| Sunday, January 1, 2017 | 40303878 | 264600000 |
| Monday, January 1, 2018 | 105285576 | 357900000 |
| Tuesday, January 1, 2019 | 220968770 | 1182600000 |
| Wednesday, January 1, 2020 | 299921000 | 357700000 |
| Friday, January 1, 2021 | 420869000 | 540100000 |
| Saturday, January 1, 2022 | 387236000 | 322900000 |
| Sunday, January 1, 2023 | 354387000 | 408000000 |
Unleashing the power of data
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, United Therapeutics Corporation and Apellis Pharmaceuticals, Inc. have demonstrated contrasting yet intriguing R&D investment strategies.
From 2014 to 2023, United Therapeutics consistently allocated substantial resources to R&D, peaking in 2019 with a remarkable 1.18 billion USD. This commitment underscores their dedication to pioneering treatments and maintaining a competitive edge. Meanwhile, Apellis Pharmaceuticals, a relatively younger player, exhibited a dynamic growth trajectory in R&D spending, surging from a modest 8 million USD in 2014 to an impressive 421 million USD in 2021.
This data not only highlights the strategic priorities of these companies but also reflects broader industry trends where innovation is paramount. As the biopharmaceutical sector continues to expand, understanding these investment patterns offers valuable insights into future breakthroughs.
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.